Skip to main content
Equibles

KBC Group NV

Position in CSTL — Castle Biosciences Inc

CIK 1411133 Brussels, C9
Back to CSTL Full portfolio

Position in CSTL

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$859,601
-$47,079 QoQ
Shares Held
36,042
-2.4% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 176 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in CSTL Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

KBC Group NV holds $446,066,148 across 24 Diagnostics & Research names. CSTL ranks #15 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IQV
Iqvia Holdings Inc.
 747,974 $144,523,534
2 TMO
Thermo Fisher Scientific Inc.
 197,810 $99,174,020
3 IDXX
Idexx Laboratories Inc /De
 113,614 $59,810,953
4 DHR
Danaher Corp /De/
 268,957 $51,230,928
5 LH
Labcorp Holdings Inc.
 105,543 $29,552,040
6 DGX
Quest Diagnostics Inc
 54,912 $11,638,597
7 A
Agilent Technologies, Inc.
 81,883 $10,876,518
8 ILMN
Illumina, Inc.
 54,388 $9,563,041

All Filings in CSTL

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $859,601 36,042
2026-03-31 $906,680 36,932